8-K: U.S. Physical Therapy Reports Strong Q2 2026 Results

U.S. Physical Therapy announced robust second quarter 2026 results, highlighted by record visit volumes, a strong net rate, and progress in hospital affiliation partnerships.

Summary

• U.S. Physical Therapy reported total revenue of $214 million for Q2 2026, an 8.5% increase year-over-year.
• Physical therapy revenue grew 8.4% to $182 million, with mature clinics showing a 3.5% increase.
• Visits per clinic per day reached an all-time high of 33.5, with 24 consecutive months of record volumes.
• The company's net rate per visit was a record $107.59, up $2.26 from the prior year.
• Industrial Injury Prevention (IIP) revenue increased by 9.1% to $32 million.
• Adjusted EBITDA was $27.0 million, flat compared to Q2 2025, while adjusted operating results were $11.3 million, down from $12.4 million.
• Net income attributable to shareholders was $9.9 million, down from $12.4 million in Q2 2025.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with strong operational performance and strategic initiatives driving future growth, despite some short-term cost pressures.

Positives

• Record high visit volumes per clinic per day at 33.5, marking a sustained trend of strong patient engagement.
• Achieved a record net rate of $107.59 per visit, reflecting improved pricing power across commercial, Medicare, and workers' compensation.
• Significant year-over-year revenue growth of 8.5% to $214 million, driven by both physical therapy and industrial injury prevention segments.
• Successful transition of 60 Metro clinics into the NYU Langone affiliation, with 50 clinicians hired in advance to support growth.
• Reaffirmation of full-year 2026 adjusted EBITDA guidance between $102 million and $106 million.
• Completion of a 12-clinic acquisition for $16.4 million, adding $12 million in annual revenue and 112,000 annual visits.
• Upsized credit facility to $450 million, enhancing liquidity and providing capacity for future acquisitions.

Negatives

• Adjusted operating results decreased to $11.3 million from $12.4 million in the prior year.
• Net income attributable to shareholders decreased to $9.9 million from $12.4 million in the prior year.
• Increased interest expense to $3.2 million from $2.4 million in the prior year.
• Higher-than-average self-insured healthcare costs, contributing approximately $3.2 million more than the prior year.
• Physical therapy gross profit margin decreased to 19.9% from 21.4% due to healthcare costs and hospital implementation expenses.

Risks

• Self-insured healthcare costs are running well ahead of usual costs due to a small number of significant claims.
• Short-term cost absorption related to upfront hiring for new hospital affiliation partnerships.
• Potential variability in commercial payer rate increases due to contract timing and negotiation cycles.
• Integration costs and potential delays associated with rolling out new finance and HR systems by early 2027.

Future Outlook

The company reaffirms its full-year 2026 adjusted EBITDA guidance of $102 million to $106 million. Management anticipates significant positive impacts in 2027 from ongoing hospital affiliations, expected Medicare rate increases, and continued commercial rate lift. The company is also developing digital and hybrid opportunities for 2027.

Management Comments

• Volumes across the company are and have been very strong, with visits per clinic per day at an all-time high this quarter at 33.5 per day.
• The transition of our NYU-affiliated clinics has gone very well, and we will benefit from approximately 50 clinicians hired in advance, which will drive the opportunity for growth going forward.
• Our year-over-year growth at Metro, from a volume perspective, significantly exceeds 100,000 visits, and that was before we had the support of our NYU Langone affiliated partners.
• We had an opportunity to hire clinicians coming out of school who were available, and we know were going to be in a position to grow this business, so we jumped on that.
• Our year-over-year growth at Metro, from a volume perspective, significantly exceeds 100,000 visits, and that was before we had the support of our NYU Langone affiliated partners.
• The pipeline of hospital development opportunities continues to grow, and we expect further relationships like the one with NYU, which will positively impact our 2027 outlook in a meaningful way.
• We are continuing to pursue good accretive opportunities where care is superior, and the forward trajectory looks good in both the PT and the injury prevention spaces.

Industry Context

StockSavvy.ai notes that U.S. Physical Therapy's performance aligns with a broader trend in the healthcare sector towards strategic partnerships with hospital systems to enhance patient access and referral networks. The record visit volumes and net rate increases suggest strong demand for outpatient physical therapy services, even amidst rising healthcare costs.

Comparison to Industry Standards

• The company's visits per clinic per day of 33.5 are reported as an all-time high, exceeding previous benchmarks set by the company.
• The net rate of $107.59 per visit is a record for the company, showing an increase over the prior year's comparable period.
• Same-store revenue growth for PT was north of 3%, which is a solid performance in a competitive outpatient therapy market.
• IIP margins were steady, slightly above 20%, which is generally considered a healthy margin for this segment.
• The company's strategy of hospital affiliations mirrors trends seen in larger healthcare systems seeking to integrate outpatient services for better continuum of care and referral capture.

Stakeholder Impact

• Shareholders: Reaffirmed EBITDA guidance and strong operational metrics suggest continued value creation, though net income was down year-over-year.
• Employees: Hiring of 50 clinicians in advance for hospital affiliations indicates investment in workforce to support growth.
• Hospital Partners: Successful integration of clinics into hospital systems strengthens these partnerships and revenue streams.
• Creditors: An upsized credit facility provides enhanced liquidity and financial flexibility.

Next Steps

• Transition the remaining 39 existing clinics into hospital affiliations during the third quarter.
• Continue the rollout of the WelcomeWare initiative to improve front desk efficiency.
• Upgrade finance and HR systems with an expected go-live at the beginning of 2027.
• Pursue further hospital affiliation partnerships and M&A opportunities.
• Continue to monitor and manage self-insured healthcare costs.

Key Dates

Recommendation

The company demonstrates strong operational execution with record volumes and pricing, and strategic progress with hospital affiliations. However, the decrease in net income and adjusted operating results, coupled with increased interest expense and healthcare costs, warrants a cautious 'hold' until these headwinds are fully mitigated and the benefits of new affiliations are more fully realized in the financials.

Keywords

physical therapy, outpatient clinics, hospital affiliations, revenue growth, earnings call, Medicare, workers compensation, acquisitions